ロード中...
Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer
Purpose: Standard chemoradiation therapy for stage III non-small cell lung cancer (NSCLCa) results in suboptimal outcomes with a high rate of local failure and poor overall survival. We hypothesize that dose escalation using stereotactic body radiotherapy (SBRT) boost could improve upon these result...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Research Foundation
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3458262/ https://ncbi.nlm.nih.gov/pubmed/23057009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2012.00124 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|